Epigenomic (DNA methylation and expression) signatures define subsets of both IDHmut and IDHwt glioma with distinct clinical outcomes (2015)
- Authors:
- Autor USP: NOUSHMEHR, HOUTAN - FMRP
- Unidade: FMRP
- DOI: 10.1093/neuonc/nov214.14
- Subjects: METILAÇÃO DE DNA; GLIOMA; DNA; GENOMAS
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Neuro-Oncology
- ISSN: 1522-8517
- Volume/Número/Paginação/Ano: v. 17, suppl. 5, res. EPIG-14, 2015
- Conference titles: Annual Scientific Meeting of the Society for Neuro-Oncology
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: bronze
-
ABNT
MALTA, Tathiane et al. Epigenomic (DNA methylation and expression) signatures define subsets of both IDHmut and IDHwt glioma with distinct clinical outcomes. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1093/neuonc/nov214.14. Acesso em: 23 abr. 2024. , 2015 -
APA
Malta, T., Sabedot, T., Ceccarelli, M., Barthel, F., Pagnotta, S., Lavarone, A., et al. (2015). Epigenomic (DNA methylation and expression) signatures define subsets of both IDHmut and IDHwt glioma with distinct clinical outcomes. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1093/neuonc/nov214.14 -
NLM
Malta T, Sabedot T, Ceccarelli M, Barthel F, Pagnotta S, Lavarone A, Verhaak R, Noushmehr H. Epigenomic (DNA methylation and expression) signatures define subsets of both IDHmut and IDHwt glioma with distinct clinical outcomes [Internet]. Neuro-Oncology. 2015 ; 17[citado 2024 abr. 23 ] Available from: https://doi.org/10.1093/neuonc/nov214.14 -
Vancouver
Malta T, Sabedot T, Ceccarelli M, Barthel F, Pagnotta S, Lavarone A, Verhaak R, Noushmehr H. Epigenomic (DNA methylation and expression) signatures define subsets of both IDHmut and IDHwt glioma with distinct clinical outcomes [Internet]. Neuro-Oncology. 2015 ; 17[citado 2024 abr. 23 ] Available from: https://doi.org/10.1093/neuonc/nov214.14 - Charting epigenomic signatures in CpG island methylator phenotype (CIMP) tumors
- Whole genome DNA is distinctly methylated in functioning and non-functioning pituitary macroadenomas
- The functionality of prostate cancer predisposition risk regions is revealed by AR enhancers
- Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31
- The cancer genome atlas pan-cancer analysis project
- Genome-wide fingerprinting of regulatory chromatin to evaluate the tissue specific origins of high-grade serous ovarian cancer
- Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin
- Src as a novel therapeutic target for endometriosis
- Prognostic significance of epigenetic subtypes and CPGS associated with progression to G-CIMP low in the eortc randomized phase III intergroup catnon
- Methylation-based liquid biopsy of meningioma primary and recurrent samples
Informações sobre o DOI: 10.1093/neuonc/nov214.14 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
